Ledger.Open graph →
SEC Form D · Amendment · filed November 22, 2021

Novosteo Inc

Offering
$14.3M
Sold
$8.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WEST LAFAYETTE, IN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Philip S. Low, Ph.D · West Lafayette, INExec · DirectorDaniel S. Hasler · West Lafayette, INDirectorAlex S. Andrianopoulos · West Lafayette, INDirectorDirk Thye, M.D · West Lafayette, INExec · DirectorMartin S. Brena, Ph.D · West Lafayette, INDirectorWilliam Rahm · Dallas, TXDirectorLaura S. Gilham · Dallas, TXExec · DirectorOcean Arete Limited · Central, Hong KongDirectorCopernico Capital Partners (Bermuda) Ltd · Hamilton, BermudaExec · DirectorJay R. Schmelter · Austin, TXDirectorToshiyuki Okayasu · Tokyo, M0Exec · DirectorRicky Sim · Tokyo, M0DirectorChris Asimakis · Toronto, Ontario, CanadaDirectorWalker Forehand · Washington, Washington, D.C.DirectorPeter J. Loughran · Chicago, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗